Answer
Trumenba contains factor H binding protein (fHbp) variants from subfamilies A and B to stimulate antibodies that recognise bacterial surface fHbp and work with human complement to kill meningococcal group B bacteria.
Sources for this answer
- Trumenba suspension for injection in pre-filled syringePfizer Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 17Document updated
Sources checked